Details of Host Protein-DME Interaction (HOSPPI)
General Information of Drug-Metabolizing Enzyme (DME ID: DME0038) | |||||
---|---|---|---|---|---|
DME Name | Vitamin D(3) 24-hydroxylase (CYP24A1), Homo sapiens | DME Info | |||
UniProt ID | |||||
EC Number | EC: 1.14.15.16 (Click to Show/Hide the Complete EC Tree) | ||||
Lineage | Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage) | ||||
Interactome |
Disease Specific Interactions between Host Protein and DME (HOSPPI) | |||||
---|---|---|---|---|---|
ICD Disease Classification Healthy | |||||
ICD-11: Healthy | Click to Show/Hide the Full List of HOSPPI: 2 HOSPPI | ||||
Transcription-factor regulation | |||||
Nuclear receptor family 2 C2 (NR2C2) | Health | Repression | |||
Uniprot ID | |||||
Interaction Name | NR2C2-CYP24A1 interaction | [1] | |||
Studied Cell Lines | Escherichia coli BL21(DE3) cell line | ||||
Description | Nuclear receptor family 2 C2 (NR2C2) is reported to repress the transcription of CYP24A1 gene, which leads to a decreased expression of the drug-metabolizing enzyme Vitamin D(3) 24-hydroxylase. As a result, the interaction between NR2C2 and CYP24A1 can repress the drug-metabolizing process of Vitamin D(3) 24-hydroxylase. | ||||
Vitamin D3 receptor (VDR) | Health | Repression | |||
Uniprot ID | |||||
Interaction Name | VDR-CYP24A1 interaction | [2] | |||
Studied Cell Lines | COS-1, CV-1 and 293-T cell lines | ||||
Ensembl ID | |||||
Description | Vitamin D3 receptor (VDR) is reported to repress the transcription of CYP24A1 gene, which leads to a decreased expression of the drug-metabolizing enzyme Vitamin D(3) 24-hydroxylase. As a result, the interaction between VDR and CYP24A1 can repress the drug-metabolizing process of Vitamin D(3) 24-hydroxylase. | ||||
ICD Disease Classification 02 Neoplasms | |||||
ICD-11: 2B90 Colorectal cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
Transcription-factor regulation | |||||
Vitamin D3 receptor (VDR) | Colorectal cancer | Activation | |||
Uniprot ID | |||||
Interaction Name | VDR-CYP24A1 interaction | [3] | |||
Studied Cell Lines | Colorectal adenocarcinomas cell line | ||||
Ensembl ID | |||||
Description | Vitamin D3 receptor (VDR) is reported to activate the transcription of CYP24A1 gene, which leads to an increased expression of the drug-metabolizing enzyme Vitamin D(3) 24-hydroxylase. As a result, the interaction between VDR and CYP24A1 can activate the drug-metabolizing process of Vitamin D(3) 24-hydroxylase. | ||||
ICD-11: 2C60 Breast cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
Non-coding RNA regulation | |||||
hsa-miR-125b-5p | Breast cancer | Suppression | |||
miRBase ID | |||||
Interaction Name | hsa-miR-125b-5p--CYP24A1 regulation | [4] | |||
Studied Cell Lines | MCF-7 cell line | ||||
Description | hsa-miR-125b-5p is reported to suppress CYP24A1 mRNA translation by binding to the 3' untranslated region (3'UTR) of CYP24A1 mRNA, which leads to a decreased expression of the drug-metabolizing enzyme Vitamin D(3) 24-hydroxylase. | ||||
ICD-11: 2C82 Prostate cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
Histone modification | |||||
Histone deacetylases (HDACs) | Prostate cancer | Repression | |||
Uniprot ID | |||||
Interaction Name | HDACs-CYP24A1 interaction | [5] | |||
Studied Cell Lines | Prostate cancer cells | ||||
Description | Histone deacetylases (HDACs) are reported to deacetylate the CYP24A1 gene and thereby repress the transcriptional activity of the drug-metabolizing enzyme Vitamin D(3 24-hydroxylase. As a result, the interaction between HDACs and CYP24A1 can inhibit the drug-metabolizing process of Vitamin D(3 24-hydroxylase. | ||||
ICD-11: 2D50 Brain cancer metastasis | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Esthesioneuroblastoma | Significant hypomethylation | |||
Interaction Name | DNMT-CYP24A1 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypomethylation p-value: 1.57E-04; delta-beta: -3.04E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the CYP24A1 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Vitamin D(3) 24-hydroxylase. As a result, the interaction between DNMT and CYP24A1 can significantly affect the drug-metabolizing process of Vitamin D(3) 24-hydroxylase. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.